Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Semaglutide may help some skin disorders but can also cause skin issues.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Acitretin can cause excess tissue growth and hair loss.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.